-
1
-
-
84973424799
-
-
February
-
Scott Levin's PPDA, MAT. February 1999.
-
(1999)
-
-
-
2
-
-
84944662266
-
A new series of anticonvulsant drugs tested by experiments on animals
-
Merritt HH, Putnam TJ. A new series of anticonvulsant drugs tested by experiments on animals. Arch Neurol Psychiatry. 1938;39:1003-1015.
-
(1938)
Arch Neurol Psychiatry.
, vol.39
, pp. 1003-1015
-
-
Merritt, H.H.1
Putnam, T.J.2
-
3
-
-
37049223719
-
Experimental determination of anticonvulsant properties of some phenyl derivatives
-
Putnam TJ, Merritt HH. Experimental determination of anticonvulsant properties of some phenyl derivatives. Science. 1937;85:525-526.
-
(1937)
Science.
, vol.85
, pp. 525-526
-
-
Putnam, T.J.1
Merritt, H.H.2
-
4
-
-
84942475840
-
Sodium diphenylhydantoinate in treatment of convulsive disorders
-
Merritt HH, Putnam TJ. Sodium diphenylhydantoinate in treatment of convulsive disorders. J Am Med Assoc. 1938;111:1068-1073.
-
(1938)
J Am Med Assoc.
, vol.111
, pp. 1068-1073
-
-
Merritt, H.H.1
Putnam, T.J.2
-
5
-
-
84891512934
-
Other hydantoins: mephenytoin and ethotoin
-
Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
-
Kupferberg HJ. Other hydantoins: mephenytoin and ethotoin. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:257-266.
-
(1989)
Antiepileptic Drugs.
, pp. 257-266
-
-
Kupferberg, H.J.1
-
7
-
-
0021250891
-
Ethotoin in seizures of childhood and adolescence
-
Carter CA, Helms RA, Boehm R. Ethotoin in seizures of childhood and adolescence. Neurology. 1984;34:791-795.
-
(1984)
Neurology.
, vol.34
, pp. 791-795
-
-
Carter, C.A.1
Helms, R.A.2
Boehm, R.3
-
8
-
-
0025325288
-
Adjunctive therapy for intractable epilepsy with ethotoin
-
Biton V, Gates JR, Ritter FJ, et al. Adjunctive therapy for intractable epilepsy with ethotoin. Epilepsia. 1990;31:433-437.
-
(1990)
Epilepsia.
, vol.31
, pp. 433-437
-
-
Biton, V.1
Gates, J.R.2
Ritter, F.J.3
-
9
-
-
0020961246
-
Hydantoin-induced teratogenesis: are arene oxide intermediates really responsible?
-
Finnell RH, Dilibert JH. Hydantoin-induced teratogenesis: are arene oxide intermediates really responsible? Helv Paediatr Acta. 1983;38: 171-177.
-
(1983)
Helv Paediatr Acta.
, vol.38
, pp. 171-177
-
-
Finnell, R.H.1
Dilibert, J.H.2
-
10
-
-
0017605311
-
Cleft lip and palate with the anticonvulsant ethotoin
-
Zablen M, Brand N. Cleft lip and palate with the anticonvulsant ethotoin. N Engl J Med. 1977;297:1404.
-
(1977)
N Engl J Med.
, vol.297
, pp. 1404
-
-
Zablen, M.1
Brand, N.2
-
12
-
-
84939114392
-
Other succinimides: methsuximide and phensuximide
-
Woodbury DM, Penry JK, Schmidt RP, eds.New York: Raven Press
-
Glazko AJ, Dill WA. Other succinimides: methsuximide and phensuximide. In: Woodbury DM, Penry JK, Schmidt RP, eds. Antiepileptic Drugs. New York: Raven Press; 1972:455-464.
-
(1972)
Antiepileptic Drugs.
, pp. 455-464
-
-
Glazko, A.J.1
Dill, W.A.2
-
13
-
-
0018693180
-
Plasma concentrations of phensuximide, methsuximide and their metabolites in relation to clinical efficacy
-
Porter RJ, Penry JK, Lacy IR, et al. Plasma concentrations of phensuximide, methsuximide and their metabolites in relation to clinical efficacy. Neurology. 1979;29:1509-1513.
-
(1979)
Neurology.
, vol.29
, pp. 1509-1513
-
-
Porter, R.J.1
Penry, J.K.2
Lacy, I.R.3
-
14
-
-
0016139051
-
Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy
-
Strong JM, Abe R, Gibbs EL, et al. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy. Neurology. 1974;24:250-255.
-
(1974)
Neurology.
, vol.24
, pp. 250-255
-
-
Strong, J.M.1
Abe, R.2
Gibbs, E.L.3
-
15
-
-
0019401620
-
Methsuximide for refractory complex partial seizures
-
Wilder BJ, Buchanan RB. Methsuximide for refractory complex partial seizures. Neurology. 1981;31:741-744.
-
(1981)
Neurology.
, vol.31
, pp. 741-744
-
-
Wilder, B.J.1
Buchanan, R.B.2
-
16
-
-
0020674597
-
Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions
-
Browne TR, Feldman RG, Buchanan RA, et al. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology. 1983;33:414-418.
-
(1983)
Neurology.
, vol.33
, pp. 414-418
-
-
Browne, T.R.1
Feldman, R.G.2
Buchanan, R.A.3
-
17
-
-
0343495513
-
N-methyl-2-methylphenyl-succinimide, in psychomotor epilepsy
-
Coroba EF, Strobos RRJ. N-methyl-2-methylphenyl-succinimide, in psychomotor epilepsy. Dis Nerv Syst. 1956;17:383-385.
-
(1956)
Dis Nerv Syst.
, vol.17
, pp. 383-385
-
-
Coroba, E.F.1
Strobos, R.R.J.2
-
19
-
-
0343931315
-
Methsuximide in psychomotor and petit mal seizures
-
French EG, Rey-Bellet J, Lennox WG. Methsuximide in psychomotor and petit mal seizures. N Engl J Med. 1958;253:892-894.
-
(1958)
N Engl J Med.
, vol.253
, pp. 892-894
-
-
French, E.G.1
Rey-Bellet, J.2
Lennox, W.G.3
-
20
-
-
0343495512
-
Celontin in the treatment of epilepsy
-
Livingston S, Pauli L. Celontin in the treatment of epilepsy. Pediatrics. 1957;19:614-618.
-
(1957)
Pediatrics.
, vol.19
, pp. 614-618
-
-
Livingston, S.1
Pauli, L.2
-
21
-
-
0343495507
-
Use of N-methyl-a,-a-methylphenylsuccinimide in the treatment of petit mal epilepsy
-
Zimmerman FT, Burgemeister BB. Use of N-methyl-a,-a-methylphenylsuccinimide in the treatment of petit mal epilepsy. Arch Neurol Psychiatry. 1954;72:720-725.
-
(1954)
Arch Neurol Psychiatry.
, vol.72
, pp. 720-725
-
-
Zimmerman, F.T.1
Burgemeister, B.B.2
-
22
-
-
84973424646
-
Methsuximide
-
Kutt H, Resor SR, eds.New York: Marcel Dekker:
-
Uthman BM, Wilder BJ. Methsuximide. In: Kutt H, Resor SR, eds. Medical Treatment of Epilepsy. New York: Marcel Dekker; 1991: 379-384.
-
(1991)
Medical Treatment of Epilepsy.
, pp. 379-384
-
-
Uthman, B.M.1
Wilder, B.J.2
-
23
-
-
0035010804
-
Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood
-
Sigler M, Strassburg HM, Boenigk HE. Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood. Seizure. 2001;10: 120-124.
-
(2001)
Seizure.
, vol.10
, pp. 120-124
-
-
Sigler, M.1
Strassburg, H.M.2
Boenigk, H.E.3
-
25
-
-
0342625340
-
Use of Celontin in the treatment of mixed epilepsy
-
Carter CH, Maley MC. Use of Celontin in the treatment of mixed epilepsy. Neurology. 1957;7:483-484.
-
(1957)
Neurology.
, vol.7
, pp. 483-484
-
-
Carter, C.H.1
Maley, M.C.2
-
28
-
-
0342625339
-
N-methyl-a,a-methylphenylsuccinimide in psychomotor epilepsy treatment
-
Zimmerman FT. N-methyl-a,a-methylphenylsuccinimide in psychomotor epilepsy treatment. Arch Neurol Psychiatry. 1956;76:65-71.
-
(1956)
Arch Neurol Psychiatry.
, vol.76
, pp. 65-71
-
-
Zimmerman, F.T.1
-
29
-
-
0004960971
-
Minor motor epilepsy: diagnosis, treatment and prognosis
-
Livingston S, Eisner V, Pauli L. Minor motor epilepsy: diagnosis, treatment and prognosis. Pediatrics. 1958;21:916-928.
-
(1958)
Pediatrics.
, vol.21
, pp. 916-928
-
-
Livingston, S.1
Eisner, V.2
Pauli, L.3
-
30
-
-
0342625322
-
Celontin (Petinutin)-a contribution to the differential therapy of epilepsy [German]
-
Rabe F. Celontin (Petinutin)-a contribution to the differential therapy of epilepsy [German]. Nervenarzt. 1960;7:306-312.
-
(1960)
Nervenarzt.
, vol.7
, pp. 306-312
-
-
Rabe, F.1
-
32
-
-
0029867296
-
Methsuximide therapy of juvenile myoclonic epilepsy
-
Hurst DL. Methsuximide therapy of juvenile myoclonic epilepsy. Seizure. 1996;5:47-50.
-
(1996)
Seizure.
, vol.5
, pp. 47-50
-
-
Hurst, D.L.1
-
33
-
-
0018397002
-
Pharmacological interactions of methsuximide with phenobarbital and phenytoin in hospitalized epileptic patients
-
Rambeck B. Pharmacological interactions of methsuximide with phenobarbital and phenytoin in hospitalized epileptic patients. Epilepsia. 1979;20:147-156.
-
(1979)
Epilepsia.
, vol.20
, pp. 147-156
-
-
Rambeck, B.1
-
34
-
-
0018616686
-
Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy
-
Eichelbaum M, Kothe KW, Hoffmann F, et al. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy. Clin Pharmacol Ther. 1979;26:366-371.
-
(1979)
Clin Pharmacol Ther.
, vol.26
, pp. 366-371
-
-
Eichelbaum, M.1
Kothe, K.W.2
Hoffmann, F.3
-
35
-
-
0032946127
-
Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study
-
May T, Rambeck B, Jurgens U. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study. Ther Drug Monit. 1999;21:175-181.
-
(1999)
Ther Drug Monit.
, vol.21
, pp. 175-181
-
-
May, T.1
Rambeck, B.2
Jurgens, U.3
-
36
-
-
0035184525
-
Methsuximide reduces valproic acid serum levels
-
Besag FM, Berry DJ, Vasey M. Methsuximide reduces valproic acid serum levels. Ther Drug Monit. 2001;23:694-697.
-
(2001)
Ther Drug Monit.
, vol.23
, pp. 694-697
-
-
Besag, F.M.1
Berry, D.J.2
Vasey, M.3
-
37
-
-
0036786119
-
Does lamotrigine influence valproate concentrations?
-
Mataringa MI, May TW, Rambeck B. Does lamotrigine influence valproate concentrations? Ther Drug Monit. 2002;24:631-636.
-
(2002)
Ther Drug Monit.
, vol.24
, pp. 631-636
-
-
Mataringa, M.I.1
May, T.W.2
Rambeck, B.3
-
38
-
-
0034098269
-
Methsuximide lower lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction
-
Besag FM. Methsuximide lower lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction. Epilepsia. 2000;41:624-627.
-
(2000)
Epilepsia.
, vol.41
, pp. 624-627
-
-
Besag, F.M.1
-
39
-
-
0036001230
-
Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication
-
May TW, Rambeck B, Jurgens U. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication. Ther Drug Monit. 2002;24:366-374.
-
(2002)
Ther Drug Monit.
, vol.24
, pp. 366-374
-
-
May, T.W.1
Rambeck, B.2
Jurgens, U.3
-
40
-
-
0025723419
-
Methsuximide-induced movement disorder
-
Dooley J, Camfield P, Buckley D, et al. Methsuximide-induced movement disorder. Pediatrics. 1991;88:1291-1292.
-
(1991)
Pediatrics.
, vol.88
, pp. 1291-1292
-
-
Dooley, J.1
Camfield, P.2
Buckley, D.3
-
41
-
-
0015837008
-
Methsuximide overdose: delayed onset of profound coma
-
Karch SB. Methsuximide overdose: delayed onset of profound coma. J Am Med Assoc. 1973;223:1463-1465.
-
(1973)
J Am Med Assoc.
, vol.223
, pp. 1463-1465
-
-
Karch, S.B.1
-
42
-
-
0018940159
-
Charcoal hemoperfusion in the therapy for methsuximide and phenytoin overdose
-
Baehler RW, Work J, Smith W, et al. Charcoal hemoperfusion in the therapy for methsuximide and phenytoin overdose. Arch Intern Med. 1980;140:1466-1468.
-
(1980)
Arch Intern Med.
, vol.140
, pp. 1466-1468
-
-
Baehler, R.W.1
Work, J.2
Smith, W.3
-
43
-
-
0001072003
-
Luminal bei Epilepsie
-
Hauptman A. Luminal bei Epilepsie. Munch Med Wochenschr. 1912;59: 1907-1909.
-
(1912)
Munch Med Wochenschr.
, vol.59
, pp. 1907-1909
-
-
Hauptman, A.1
-
44
-
-
0021887675
-
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures
-
Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med. 1985;313:145-151.
-
(1985)
N Engl J Med.
, vol.313
, pp. 145-151
-
-
Mattson, R.H.1
Cramer, J.A.2
Collins, J.F.3
-
45
-
-
0025012995
-
Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence
-
Farwell JR, Lee YJ, Hirtz DG, et al. Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364-369.
-
(1990)
N Engl J Med.
, vol.322
, pp. 364-369
-
-
Farwell, J.R.1
Lee, Y.J.2
Hirtz, D.G.3
-
46
-
-
0023028242
-
Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial
-
Goldberg RN, Moscoso P, Bauer CR, et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr. 1986;109:851-856.
-
(1986)
J Pediatr.
, vol.109
, pp. 851-856
-
-
Goldberg, R.N.1
Moscoso, P.2
Bauer, C.R.3
-
48
-
-
0041755459
-
How to use phenobarbital
-
Morselli PL, Pippenger CE, Penry JK, eds.New York: Raven Press
-
Painter MJ. How to use phenobarbital. In: Morselli PL, Pippenger CE, Penry JK, eds. Antiepileptic Drug Therapy in Pediatrics. New York: Raven Press; 1983:245-250.
-
(1983)
Antiepileptic Drug Therapy in Pediatrics.
, pp. 245-250
-
-
Painter, M.J.1
-
49
-
-
0021274545
-
Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants: a controlled study of bilirubin disappearance and infant behavior
-
Wallin A, Boreus LO. Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants: a controlled study of bilirubin disappearance and infant behavior. Acta Pediatr Scand. 1984;73:488-497.
-
(1984)
Acta Pediatr Scand.
, vol.73
, pp. 488-497
-
-
Wallin, A.1
Boreus, L.O.2
-
50
-
-
84912847588
-
Phenobarbital mechanisms of action
-
Woodbury D, Penry JK, Pippenger CE, eds.2nd ed. New York: Raven Press
-
Pritchard JW. Phenobarbital mechanisms of action. In: Woodbury D, Penry JK, Pippenger CE, eds. Antiepileptic Drugs. 2nd ed. New York: Raven Press; 1982:1332-1335.
-
(1982)
Antiepileptic Drugs.
, pp. 1332-1335
-
-
Pritchard, J.W.1
-
51
-
-
0019402780
-
Qualitative and quantitative studies of methylphenobarbital metabolism in man
-
Hooper WD, Kunze HE, Eadie MJ. Qualitative and quantitative studies of methylphenobarbital metabolism in man. Drug Metab. 1981;9:381-385.
-
(1981)
Drug Metab.
, vol.9
, pp. 381-385
-
-
Hooper, W.D.1
Kunze, H.E.2
Eadie, M.J.3
-
52
-
-
0014991269
-
Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats
-
Craig CR, Shideman FE. Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats. J Pharmacol Exp Ther. 1971; 176:35-41.
-
(1971)
J Pharmacol Exp Ther.
, vol.176
, pp. 35-41
-
-
Craig, C.R.1
Shideman, F.E.2
-
53
-
-
0014912667
-
Stereospecificity of anaesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates
-
Buch H, Knabe J, Buzello W, et al. Stereospecificity of anaesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. J Pharmacol Exp Ther. 1970;176:709-716.
-
(1970)
J Pharmacol Exp Ther.
, vol.176
, pp. 709-716
-
-
Buch, H.1
Knabe, J.2
Buzello, W.3
-
54
-
-
50549218994
-
Demethylation of N-methyl derivatives of barbituric acid, hydantoin and 2,4-oxazolidinedione by rat liver microsomes
-
Smith JA, Waddell WJ, Butler TC. Demethylation of N-methyl derivatives of barbituric acid, hydantoin and 2,4-oxazolidinedione by rat liver microsomes. Life Sci. 1963;7:486-492.
-
(1963)
Life Sci.
, vol.7
, pp. 486-492
-
-
Smith, J.A.1
Waddell, W.J.2
Butler, T.C.3
-
55
-
-
0006462822
-
The role of the liver in the metabolic disposition of mephobarbital
-
Butler TC, Mahaffee D, Mahaffee C. The role of the liver in the metabolic disposition of mephobarbital. J Pharmacol Exp Ther. 1952;106:364-369.
-
(1952)
J Pharmacol Exp Ther.
, vol.106
, pp. 364-369
-
-
Butler, T.C.1
Mahaffee, D.2
Mahaffee, C.3
-
56
-
-
4143079138
-
Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of Rand S-mephobarbital in humans
-
Kobayashi K, Morita J, Chiba K, et al. Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of Rand S-mephobarbital in humans. Pharmacogenetics. 2004;14(8):549-556.
-
(2004)
Pharmacogenetics.
, vol.14
, Issue.8
, pp. 549-556
-
-
Kobayashi, K.1
Morita, J.2
Chiba, K.3
-
57
-
-
0019471999
-
Pharmacokinetics and bioavailability of methylphenobarbital in man
-
Hooper WD, Kunze HE, Eadie MJ. Pharmacokinetics and bioavailability of methylphenobarbital in man. Ther Drug Monit. 1981;3:39-44.
-
(1981)
Ther Drug Monit.
, vol.3
, pp. 39-44
-
-
Hooper, W.D.1
Kunze, H.E.2
Eadie, M.J.3
-
58
-
-
84984425031
-
Die Bekanfung epileptischer Anfalle und iher Folgeer Scheinungen mit Prominal
-
Blum E. Die Bekanfung epileptischer Anfalle und iher Folgeer Scheinungen mit Prominal. Dtsch Med Wochenschr. 1932;58:230-236.
-
(1932)
Dtsch Med Wochenschr.
, vol.58
, pp. 230-236
-
-
Blum, E.1
-
59
-
-
84883900123
-
Other barbiturates: methyl-phenobarbital and metharbital
-
Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
-
Eadie MJ. Other barbiturates: methyl-phenobarbital and metharbital. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:357-378.
-
(1989)
Antiepileptic Drugs.
, pp. 357-378
-
-
Eadie, M.J.1
-
60
-
-
0018620260
-
Mephobarbital and phenobarbital plasma concentrations in epileptic patients treated with mephobarbital
-
Kupferberg HJ, Longacre-Shaw J. Mephobarbital and phenobarbital plasma concentrations in epileptic patients treated with mephobarbital. Ther Drug Monit. 1979;1:117-122.
-
(1979)
Ther Drug Monit.
, vol.1
, pp. 117-122
-
-
Kupferberg, H.J.1
Longacre-Shaw, J.2
-
61
-
-
0014338849
-
Perceptual-motor behavior in relation to blood phenobarbital level: a preliminary report
-
Hutt SJ, Jackson PM, Belsham A, et al. Perceptual-motor behavior in relation to blood phenobarbital level: a preliminary report. Dev Med Child Neurol. 1968;10:626-632.
-
(1968)
Dev Med Child Neurol.
, vol.10
, pp. 626-632
-
-
Hutt, S.J.1
Jackson, P.M.2
Belsham, A.3
-
62
-
-
84973434623
-
-
Presented at the NIH Consensus Development Conference on Febrile Seizures; May 19-21, Bethesda, MD
-
Camfield C. Clinical Trials of Phenobarbital. Presented at the NIH Consensus Development Conference on Febrile Seizures; May 19-21, 1980; Bethesda, MD.
-
(1980)
Clinical Trials of Phenobarbital
-
-
Camfield, C.1
-
63
-
-
0018263659
-
Memory impairment in epileptic patients: selective effects of phenobarbital concentrations
-
McLeod CM, Dekaban AS, Hunt E. Memory impairment in epileptic patients: selective effects of phenobarbital concentrations. Science. 1978; 202:1102-1104.
-
(1978)
Science.
, vol.202
, pp. 1102-1104
-
-
McLeod, C.M.1
Dekaban, A.S.2
Hunt, E.3
-
64
-
-
0030980598
-
Barbiturate anticonvulsants: a neuropsychological and quantitative electroencephalographic study
-
Willis J, Nelson A, Black FW, et al. Barbiturate anticonvulsants: a neuropsychological and quantitative electroencephalographic study. J Child Neurol. 1997;12:169-171.
-
(1997)
J Child Neurol.
, vol.12
, pp. 169-171
-
-
Willis, J.1
Nelson, A.2
Black, F.W.3
-
65
-
-
77049143061
-
Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics
-
Bergstrom WH, Carzoli RF, Lombroso C, et al. Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics. Am J Dis Child. 1952;84:771-772.
-
(1952)
Am J Dis Child.
, vol.84
, pp. 771-772
-
-
Bergstrom, W.H.1
Carzoli, R.F.2
Lombroso, C.3
-
66
-
-
84965257938
-
Acetazolamide in treatment of epilepsy
-
Ansell B, Clarke E. Acetazolamide in treatment of epilepsy. Br Med J. 1956;1:650-661.
-
(1956)
Br Med J.
, vol.1
, pp. 650-661
-
-
Ansell, B.1
Clarke, E.2
-
67
-
-
0019851991
-
Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children
-
Forsythe WI, Owens JR, Toothill C. Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Dev Med Child Neurol. 1981;23:761-769.
-
(1981)
Dev Med Child Neurol.
, vol.23
, pp. 761-769
-
-
Forsythe, W.I.1
Owens, J.R.2
Toothill, C.3
-
68
-
-
3042981553
-
Control of petit mal by acetazolamide
-
Golla FL, Sessions HR. Control of petit mal by acetazolamide. J Ment Sci. 1957;103:214-217.
-
(1957)
J Ment Sci.
, vol.103
, pp. 214-217
-
-
Golla, F.L.1
Sessions, H.R.2
-
70
-
-
0000610426
-
Anticonvulsant action of Diamox in children
-
Millichap JG. Anticonvulsant action of Diamox in children. Neurology. 1956;6:552-559.
-
(1956)
Neurology.
, vol.6
, pp. 552-559
-
-
Millichap, J.G.1
-
71
-
-
0013061288
-
Carbonic anhydrase inhibition, I: the pharmacology of Diamox (2-acetylamino-1,3,4-thiadiazole-5sulfonamide)
-
Maren TH, Mayer E, Wadsworth BC. Carbonic anhydrase inhibition, I: the pharmacology of Diamox (2-acetylamino-1,3,4-thiadiazole-5sulfonamide). Bull Johns Hopkins Hosp. 1954;95:199-243.
-
(1954)
Bull Johns Hopkins Hosp.
, vol.95
, pp. 199-243
-
-
Maren, T.H.1
Mayer, E.2
Wadsworth, B.C.3
-
72
-
-
0001348448
-
Mechanism of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor
-
Millichap JG, Woodbury DM, Goodman LS. Mechanism of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor. J Pharmacol Exp Ther. 1955;115:251-258.
-
(1955)
J Pharmacol Exp Ther.
, vol.115
, pp. 251-258
-
-
Millichap, J.G.1
Woodbury, D.M.2
Goodman, L.S.3
-
73
-
-
0027511247
-
Reduced susceptibility to seizures in carbonic anhydrase II deficient mutant mice
-
Velisek L, Moshé SL, Xu SG, et al. Reduced susceptibility to seizures in carbonic anhydrase II deficient mutant mice. Epilepsy Res. 1993;14:115-121.
-
(1993)
Epilepsy Res.
, vol.14
, pp. 115-121
-
-
Velisek, L.1
Moshé, S.L.2
Xu, S.G.3
-
74
-
-
0037122779
-
Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties
-
Masereel B, Rolin S, Abbate F, et al. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem. 2002;45:312-320.
-
(2002)
J Med Chem.
, vol.45
, pp. 312-320
-
-
Masereel, B.1
Rolin, S.2
Abbate, F.3
-
75
-
-
84910591102
-
Pharmacology and mechanisms of action of antiepileptic drugs
-
Goldensohn ES, Appel SH, eds.Philadelphia, PA: Lea & Febiger
-
Woodbury DM. Pharmacology and mechanisms of action of antiepileptic drugs. In: Goldensohn ES, Appel SH, eds. Scientific Approaches to Clinical Neurology. Philadelphia, PA: Lea & Febiger; 1977:693-726.
-
(1977)
Scientific Approaches to Clinical Neurology.
, pp. 693-726
-
-
Woodbury, D.M.1
-
76
-
-
0036091187
-
Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons
-
Leniger T, Wiemann M, Bingmann D, et al. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia. 2002;43:469-474.
-
(2002)
Epilepsia.
, vol.43
, pp. 469-474
-
-
Leniger, T.1
Wiemann, M.2
Bingmann, D.3
-
77
-
-
10844237676
-
Basic mechanisms of seizures: neurophysiological and biochemical etiology
-
Shagass C, Gerson S, Friedhoff AJ, eds.New York: Raven Press
-
Woodbury DM, Kemp JW. Basic mechanisms of seizures: neurophysiological and biochemical etiology. In: Shagass C, Gerson S, Friedhoff AJ, eds. Psychopathology and Brain Dysfunction. New York: Raven Press; 1977:149-182.
-
(1977)
Psychopathology and Brain Dysfunction.
, pp. 149-182
-
-
Woodbury, D.M.1
Kemp, J.W.2
-
78
-
-
0009111688
-
Antiepileptic drugs: carbonic anhydrase inhibitors
-
Glaser GH, Penry JK, Woodbury DM, eds.New York: Raven Press
-
Woodbury DM. Antiepileptic drugs: carbonic anhydrase inhibitors. In: Glaser GH, Penry JK, Woodbury DM, eds. Antiepileptic Drugs: Mechanisms of Action. New York: Raven Press; 1980:617-634.
-
(1980)
Antiepileptic Drugs: Mechanisms of Action.
, pp. 617-634
-
-
Woodbury, D.M.1
-
79
-
-
0034992257
-
Treatment of typical absence seizures and related epileptic syndromes
-
Panayiotopoulos CP. Treatment of typical absence seizures and related epileptic syndromes. Paediatr Drugs. 2001;3:379-403.
-
(2001)
Paediatr Drugs.
, vol.3
, pp. 379-403
-
-
Panayiotopoulos, C.P.1
-
81
-
-
0025188657
-
Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy
-
Resor SR, Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology. 1990;40:1677-1681.
-
(1990)
Neurology.
, vol.40
, pp. 1677-1681
-
-
Resor, Jr.S.R.1
Resor, L.D.2
-
82
-
-
0036211076
-
Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies
-
Katayama F, Miura H, Takanashi S. Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies. Brain Dev. 2002;24:150-154.
-
(2002)
Brain Dev.
, vol.24
, pp. 150-154
-
-
Katayama, F.1
Miura, H.2
Takanashi, S.3
-
83
-
-
0029965708
-
Acetazolamide in the treatment of epilepsy
-
Reiss WG, Oles KS. Acetazolamide in the treatment of epilepsy. Ann Pharmacother. 1996;30:514-519.
-
(1996)
Ann Pharmacother.
, vol.30
, pp. 514-519
-
-
Reiss, W.G.1
Oles, K.S.2
-
84
-
-
0006898943
-
Other antiepileptic drugs: sulfonamides and derivatives
-
Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
-
Woodbury DM, Kemp JW. Other antiepileptic drugs: sulfonamides and derivatives. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:855-876.
-
(1989)
Antiepileptic Drugs.
, pp. 855-876
-
-
Woodbury, D.M.1
Kemp, J.W.2
-
85
-
-
0033002623
-
Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study
-
Kubota F, Kifune A, Shibata N, et al. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res. 1999;33:93-97.
-
(1999)
Epilepsy Res.
, vol.33
, pp. 93-97
-
-
Kubota, F.1
Kifune, A.2
Shibata, N.3
-
86
-
-
0030298437
-
Growth suppression in children receiving acetazolamide with antiepileptic drugs
-
Futagi Y, Atani K, Abe J. Growth suppression in children receiving acetazolamide with antiepileptic drugs. Pediatr Neurol. 1996;15:323-326.
-
(1996)
Pediatr Neurol.
, vol.15
, pp. 323-326
-
-
Futagi, Y.1
Atani, K.2
Abe, J.3
-
87
-
-
0001890299
-
Intake of vitamin B-6 and infantile convulsions: a first approximation of requirements of pyridoxine in infants
-
Bessey OA, Adam DJD, Hansen AE. Intake of vitamin B-6 and infantile convulsions: a first approximation of requirements of pyridoxine in infants. Pediatrics. 1957;10:33-44.
-
(1957)
Pediatrics.
, vol.10
, pp. 33-44
-
-
Bessey, O.A.1
Adam, D.J.D.2
Hansen, A.E.3
-
88
-
-
0002935936
-
Ineffectiveness of pyridoxine (vitamin B-6) in the treatment of epilepsy
-
Livingston SJ, Hsu M, Petersen DC. Ineffectiveness of pyridoxine (vitamin B-6) in the treatment of epilepsy. Pediatrics. 1955;16:250-251.
-
(1955)
Pediatrics.
, vol.16
, pp. 250-251
-
-
Livingston, S.J.1
Hsu, M.2
Petersen, D.C.3
-
89
-
-
0001851634
-
Vitamin B-6-dependency infantile convulsions
-
Scriver CR. Vitamin B-6-dependency infantile convulsions. Pediatrics. 1960;26:62-74.
-
(1960)
Pediatrics.
, vol.26
, pp. 62-74
-
-
Scriver, C.R.1
-
90
-
-
0342315296
-
The vitamin B-6 deficiency syndrome in human infancy: biochemical and clinical observations
-
Scriver CR, Hutchison JH. The vitamin B-6 deficiency syndrome in human infancy: biochemical and clinical observations. Pediatrics. 1963;31:240-250.
-
(1963)
Pediatrics.
, vol.31
, pp. 240-250
-
-
Scriver, C.R.1
Hutchison, J.H.2
-
91
-
-
0000743130
-
Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine
-
Hunt AD, Stokes J, McCrory WW, et al. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954;13:140-145.
-
(1954)
Pediatrics.
, vol.13
, pp. 140-145
-
-
Hunt, A.D.1
Stokes, J.2
McCrory, W.W.3
-
92
-
-
0014696022
-
Glutamic acid decarboxylase (GAD) in mammalian tissue outside the central nervous system, and its possible relevance to hereditary vitamin B-6 dependency with seizures
-
Scriver CR, Whelan DT. Glutamic acid decarboxylase (GAD) in mammalian tissue outside the central nervous system, and its possible relevance to hereditary vitamin B-6 dependency with seizures. Ann N Y Acad Sci. 1969;166:83-96.
-
(1969)
Ann N Y Acad Sci.
, vol.166
, pp. 83-96
-
-
Scriver, C.R.1
Whelan, D.T.2
-
93
-
-
0020998093
-
Late-onset pyridoxine-dependency convulsions
-
Bachmann DS. Late-onset pyridoxine-dependency convulsions. Ann Neurol. 1983;14:692-693.
-
(1983)
Ann Neurol.
, vol.14
, pp. 692-693
-
-
Bachmann, D.S.1
-
94
-
-
0026905512
-
Postneonatal vitamin B-6-dependent epilepsy
-
Coker SB. Postneonatal vitamin B-6-dependent epilepsy. Pediatrics. 1992;90:221-223.
-
(1992)
Pediatrics.
, vol.90
, pp. 221-223
-
-
Coker, S.B.1
-
95
-
-
0023584390
-
Disappearance of neonatal seizures and low CSF GABA levels after treatment with vitamin B-6
-
Kurleman G, Loscher W, Dominick HC, et al. Disappearance of neonatal seizures and low CSF GABA levels after treatment with vitamin B-6. Epilepsy Res. 1987;1:152-154.
-
(1987)
Epilepsy Res.
, vol.1
, pp. 152-154
-
-
Kurleman, G.1
Loscher, W.2
Dominick, H.C.3
-
96
-
-
0015081685
-
Vitamin B 6-dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B 6 dependent convulsion
-
Yoshida T, Tada K, Arakawa T. Vitamin B 6-dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B 6 dependent convulsion. Tohoku J Exp Med. 1971;104:195-198.
-
(1971)
Tohoku J Exp Med.
, vol.104
, pp. 195-198
-
-
Yoshida, T.1
Tada, K.2
Arakawa, T.3
-
97
-
-
1242341236
-
Pyridoxine-dependent seizures: a clinical and biochemical conundrum
-
Baxter P. Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta. 2003;1647:36-41.
-
(2003)
Biochim Biophys Acta.
, vol.1647
, pp. 36-41
-
-
Baxter, P.1
-
98
-
-
0036214478
-
Pyridoxine-dependent seizures: findings from recent studies pose new questions
-
Gospe SM. Pyridoxine-dependent seizures: findings from recent studies pose new questions. Pediatr Neurol. 2002;26:181-185.
-
(2002)
Pediatr Neurol.
, vol.26
, pp. 181-185
-
-
Gospe, S.M.1
-
99
-
-
0020546448
-
Pyridoxine dependent seizures: a wider clinical spectrum
-
Bankier A, Turner M, Hopkins IJ. Pyridoxine dependent seizures: a wider clinical spectrum. Arch Dis Child. 1983;58:415-418.
-
(1983)
Arch Dis Child.
, vol.58
, pp. 415-418
-
-
Bankier, A.1
Turner, M.2
Hopkins, I.J.3
-
100
-
-
0021962790
-
Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants
-
Goutieres F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol. 1985;17:117-120.
-
(1985)
Ann Neurol.
, vol.17
, pp. 117-120
-
-
Goutieres, F.1
Aicardi, J.2
-
102
-
-
0025730349
-
Pyridoxine-dependent seizures, clinical therapeutic aspects
-
Haenggeli CA, Girardin E, Paunier L. Pyridoxine-dependent seizures, clinical therapeutic aspects. Eur J Pediatr. 1991;150:452-455.
-
(1991)
Eur J Pediatr.
, vol.150
, pp. 452-455
-
-
Haenggeli, C.A.1
Girardin, E.2
Paunier, L.3
-
103
-
-
0345404150
-
Longitudinal MRI findings in pyridoxinedependent seizures
-
Gospe SM, Jr, Hecht ST. Longitudinal MRI findings in pyridoxinedependent seizures. Neurology. 1998;51:74-78.
-
(1998)
Neurology.
, vol.51
, pp. 74-78
-
-
Gospe, Jr.S.M.1
Hecht, S.T.2
-
104
-
-
0018600474
-
Pyridoxine-dependent seizures requiring high doses of pyridoxine for control
-
Clarke TA, Saunders BS, Feldman B. Pyridoxine-dependent seizures requiring high doses of pyridoxine for control. Am J Dis Child. 1979;133: 963-965.
-
(1979)
Am J Dis Child.
, vol.133
, pp. 963-965
-
-
Clarke, T.A.1
Saunders, B.S.2
Feldman, B.3
-
105
-
-
0020683566
-
Pyridoxine-dependency seizure: report of a rare presentation
-
Krishnamoorthy KS. Pyridoxine-dependency seizure: report of a rare presentation. Ann Neurol. 1983;13:103-104.
-
(1983)
Ann Neurol.
, vol.13
, pp. 103-104
-
-
Krishnamoorthy, K.S.1
-
106
-
-
0029814382
-
Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion
-
Bass NE, Wyllie E, Cohen B, et al. Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol. 1996;11:422-424.
-
(1996)
J Child Neurol.
, vol.11
, pp. 422-424
-
-
Bass, N.E.1
Wyllie, E.2
Cohen, B.3
-
107
-
-
0017903491
-
Vitamin B 6-dependent seizures: pathology chemical findings in brain
-
Lott IT, Coulombe T, DiPaolo RV, et al. Vitamin B 6-dependent seizures: pathology chemical findings in brain. Neurology. 1978;28:47-54.
-
(1978)
Neurology.
, vol.28
, pp. 47-54
-
-
Lott, I.T.1
Coulombe, T.2
DiPaolo, R.V.3
-
108
-
-
0028022624
-
Glutamate in pyridoxinedependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine
-
Friedrich AM, Baumeister MD, Gsell W, et al. Glutamate in pyridoxinedependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. Pediatrics. 1994; 94:318-321.
-
(1994)
Pediatrics.
, vol.94
, pp. 318-321
-
-
Friedrich, A.M.1
Baumeister, M.D.2
Gsell, W.3
-
109
-
-
0021369529
-
Cerebrospinal fluid GABA levels in children with infantile spasms
-
Ito M, Mikawa M, Tangiguchi T. Cerebrospinal fluid GABA levels in children with infantile spasms. Neurology. 1984;34:235-238.
-
(1984)
Neurology.
, vol.34
, pp. 235-238
-
-
Ito, M.1
Mikawa, M.2
Tangiguchi, T.3
-
110
-
-
0021879046
-
Cerebrospinal fluid: aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment
-
Loscher W, Siemes H. Cerebrospinal fluid: aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia. 1985;16:314-319.
-
(1985)
Epilepsia.
, vol.16
, pp. 314-319
-
-
Loscher, W.1
Siemes, H.2
-
111
-
-
0022559678
-
High dose B-6 treatment in infantile spasms
-
Blennow G, Starck L. High dose B-6 treatment in infantile spasms. Neuropediatrics. 1986;17:7-10.
-
(1986)
Neuropediatrics.
, vol.17
, pp. 7-10
-
-
Blennow, G.1
Starck, L.2
-
112
-
-
0025921989
-
Vitamin B-6 and valproic acid in treatment of infantile spasms
-
Ito M, Okuno T, Hattori H, et al. Vitamin B-6 and valproic acid in treatment of infantile spasms. Pediatr Neurol. 1991;7:91-96.
-
(1991)
Pediatr Neurol.
, vol.7
, pp. 91-96
-
-
Ito, M.1
Okuno, T.2
Hattori, H.3
-
113
-
-
0003004212
-
Pyridoxal phosphate in the treatment of the West syndrome
-
Akimoto H, Seino M, Ward AA, Jr, eds.New York: Raven Press
-
Ohtsuka Y, Matsuda M, Kohno C, et al. Pyridoxal phosphate in the treatment of the West syndrome. In: Akimoto H, Seino M, Ward AA, Jr, eds. Advances in Epileptology. XIIIth Epilepsy International Symposium. New York: Raven Press; 1982:311-313.
-
(1982)
Advances in Epileptology. XIIIth Epilepsy International Symposium.
, pp. 311-313
-
-
Ohtsuka, Y.1
Matsuda, M.2
Kohno, C.3
-
114
-
-
0027326674
-
Treatment of infantile spasms with high-dosage vitamin B6
-
Pietz J, Benninger C, Schafer H, et al. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia. 1993;34:757-763.
-
(1993)
Epilepsia.
, vol.34
, pp. 757-763
-
-
Pietz, J.1
Benninger, C.2
Schafer, H.3
-
115
-
-
18744428938
-
Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children
-
Jiao FY, Takuma Y, Wu S, et al. Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children. Pediatr Neurol. 1997;17:54-57.
-
(1997)
Pediatr Neurol.
, vol.17
, pp. 54-57
-
-
Jiao, F.Y.1
Takuma, Y.2
Wu, S.3
-
116
-
-
36549011402
-
Vitamin B6 related epilepsy during childhood
-
Wang HS, Kuo MF. Vitamin B6 related epilepsy during childhood. Chang Gung Med J. 2007;30(5):396-401.
-
(2007)
Chang Gung Med J.
, vol.30
, Issue.5
, pp. 396-401
-
-
Wang, H.S.1
Kuo, M.F.2
-
117
-
-
1242280684
-
Pyridoxine-dependent convulsions in an infant
-
Garty R, Yonis Z, Braham J, et al. Pyridoxine-dependent convulsions in an infant. Arch Dis Child. 1962;37:21-24.
-
(1962)
Arch Dis Child.
, vol.37
, pp. 21-24
-
-
Garty, R.1
Yonis, Z.2
Braham, J.3
-
118
-
-
0022007415
-
Pyridoxine for neonatal seizures: an unexpected danger
-
Kroll J. Pyridoxine for neonatal seizures: an unexpected danger. Dev Med Child Neurol. 1985;27:369-382.
-
(1985)
Dev Med Child Neurol.
, vol.27
, pp. 369-382
-
-
Kroll, J.1
-
119
-
-
0018134207
-
Pyridoxol metabolism in vitamin B-6 responsive convulsions of early infancy
-
Heeley A, Puch RJP, Clayton BE, et al. Pyridoxol metabolism in vitamin B-6 responsive convulsions of early infancy. Arch Dis Child. 1978;53: 794-802.
-
(1978)
Arch Dis Child.
, vol.53
, pp. 794-802
-
-
Heeley, A.1
Puch, R.J.P.2
Clayton, B.E.3
-
120
-
-
0000874589
-
Experimental study of the effects produced by large doses of vitamin B-6
-
Antopol W, Tarlov IM. Experimental study of the effects produced by large doses of vitamin B-6. J Neuropathol Exp Neurol. 1942;1:330-336.
-
(1942)
J Neuropathol Exp Neurol.
, vol.1
, pp. 330-336
-
-
Antopol, W.1
Tarlov, I.M.2
-
121
-
-
0023230365
-
Characteristics of pyridoxine overdose neuropathy syndrome
-
Dalton K, Dalton JT. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76:8-11.
-
(1987)
Acta Neurol Scand.
, vol.76
, pp. 8-11
-
-
Dalton, K.1
Dalton, J.T.2
-
122
-
-
0021930611
-
Sensory neuropathy with low-dose pyridoxine
-
Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology. 1985;35:1466-1468.
-
(1985)
Neurology.
, vol.35
, pp. 1466-1468
-
-
Parry, G.J.1
Bredesen, D.E.2
-
123
-
-
0020592458
-
Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome
-
Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med. 1983; 309:445-448.
-
(1983)
N Engl J Med.
, vol.309
, pp. 445-448
-
-
Schaumburg, H.1
Kaplan, J.2
Windebank, A.3
-
124
-
-
0024420433
-
Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication
-
Xu Y, Sladky JT, Brown MJ. Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology. 1989;39:1077-1083.
-
(1989)
Neurology.
, vol.39
, pp. 1077-1083
-
-
Xu, Y.1
Sladky, J.T.2
Brown, M.J.3
-
125
-
-
0026639426
-
Dose response, coasting, and differential fibre vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity
-
Berger AR, Schaumburg HH, Schroeder C, et al. Dose response, coasting, and differential fibre vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology. 1992;42: 1367-1370.
-
(1992)
Neurology.
, vol.42
, pp. 1367-1370
-
-
Berger, A.R.1
Schaumburg, H.H.2
Schroeder, C.3
-
126
-
-
0021148334
-
More on neuropathy from pyridoxine abuse
-
Berger A, Schaumburg HH. More on neuropathy from pyridoxine abuse. N Engl J Med. 1984;311:986-987.
-
(1984)
N Engl J Med.
, vol.311
, pp. 986-987
-
-
Berger, A.1
Schaumburg, H.H.2
-
127
-
-
0023617573
-
Acute sensory neuropathy-neuronopathy from pyridoxine overdose
-
Albin R, Alpers JW, Greenberg HS, et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology. 1987;37:1729-1732.
-
(1987)
Neurology.
, vol.37
, pp. 1729-1732
-
-
Albin, R.1
Alpers, J.W.2
Greenberg, H.S.3
-
129
-
-
0008941810
-
Carpal tunnel syndrome and vitamin B-6 therapy
-
Reynolds RD, Leklem JE, eds.New York: Alan R. Liss;13
-
Del Tredici AM, Bernstein AL, Chinn K. Carpal tunnel syndrome and vitamin B-6 therapy. In: Reynolds RD, Leklem JE, eds. Vitamin B-6: Its Role in Health and Disease. Current Topics in Nutrition and Disease. New York: Alan R. Liss; 1985;13:459-462.
-
(1985)
Vitamin B-6: Its Role in Health and Disease. Current Topics in Nutrition and Disease.
, pp. 459-462
-
-
Del Tredici, A.M.1
Bernstein, A.L.2
Chinn, K.3
-
130
-
-
0021490934
-
Pyridoxine dependent seizures
-
Reynolds RD. Pyridoxine dependent seizures. Arch Dis Child. 1984;59: 906-907.
-
(1984)
Arch Dis Child.
, vol.59
, pp. 906-907
-
-
Reynolds, R.D.1
-
131
-
-
0025899377
-
No sensory neuropathy during pyridoxine treatment in homocystinuria
-
Mpofu C, Alani SM, Whitehouse C, et al. No sensory neuropathy during pyridoxine treatment in homocystinuria. Arch Dis Child. 1991;66: 1081-1082.
-
(1991)
Arch Dis Child.
, vol.66
, pp. 1081-1082
-
-
Mpofu, C.1
Alani, S.M.2
Whitehouse, C.3
-
132
-
-
0028897913
-
Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy
-
McLachlan RS, Brown WF. Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy. Can J Neurol Sci. 1995;22:50-51.
-
(1995)
Can J Neurol Sci.
, vol.22
, pp. 50-51
-
-
McLachlan, R.S.1
Brown, W.F.2
-
133
-
-
0000473045
-
Analysis of 52 cases of epilepsy observed by author
-
Locock C. In discussion of Sieveking EH. Analysis of 52 cases of epilepsy observed by author. Lancet. 1857;1:527.
-
(1857)
Lancet.
, vol.1
, pp. 527
-
-
Locock, C.1
-
134
-
-
0018577690
-
Ontogeny of GABA and benzodiazepine receptors: effects of Triton X-100, bromide and muscimol
-
Palachios JM, Nieholt DL, Kuhar MJ. Ontogeny of GABA and benzodiazepine receptors: effects of Triton X-100, bromide and muscimol. Brain Res. 1979;179:390-395.
-
(1979)
Brain Res.
, vol.179
, pp. 390-395
-
-
Palachios, J.M.1
Nieholt, D.L.2
Kuhar, M.J.3
-
135
-
-
0002521928
-
Bromides
-
Woodbury DM, Penry JK, Pippenger CE, eds.2nd ed. New York: Raven Press
-
Woodbury DM, Pippenger CE. Bromides. In: Woodbury DM, Penry JK, Pippenger CE, eds. Antiepileptic Drugs. 2nd ed. New York: Raven Press; 1986:791-801.
-
(1986)
Antiepileptic Drugs.
, pp. 791-801
-
-
Woodbury, D.M.1
Pippenger, C.E.2
-
136
-
-
0022851347
-
Pharmacokinetics of oral and intravenous bromide in normal volunteers
-
Vaiseman N, Koren G, Pencharz P. Pharmacokinetics of oral and intravenous bromide in normal volunteers. Clin Toxicol. 1986;24:403-413.
-
(1986)
Clin Toxicol.
, vol.24
, pp. 403-413
-
-
Vaiseman, N.1
Koren, G.2
Pencharz, P.3
-
137
-
-
0008917280
-
Bromides
-
Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
-
Dreifuss FE. Bromides. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:877-879.
-
(1989)
Antiepileptic Drugs.
, pp. 877-879
-
-
Dreifuss, F.E.1
-
138
-
-
0024213254
-
Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood
-
Ernst J, Doose H, Baier WK. Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood. Brain Dev. 1988;10:385-388.
-
(1988)
Brain Dev.
, vol.10
, pp. 385-388
-
-
Ernst, J.1
Doose, H.2
Baier, W.K.3
-
139
-
-
0028075820
-
Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant
-
Oguni H, Hayashi K, Oguni M, et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia. 1994;35:1140-1145.
-
(1994)
Epilepsia.
, vol.35
, pp. 1140-1145
-
-
Oguni, H.1
Hayashi, K.2
Oguni, M.3
-
140
-
-
0026734979
-
Bromide treatment of pharmaco-resistant epilepsies with generalized tonic-clonic seizures: a clinical study
-
Steinhoff BJ, Kruse R. Bromide treatment of pharmaco-resistant epilepsies with generalized tonic-clonic seizures: a clinical study. Brain Dev. 1992;14:144-149.
-
(1992)
Brain Dev.
, vol.14
, pp. 144-149
-
-
Steinhoff, B.J.1
Kruse, R.2
-
141
-
-
0035408386
-
Anticonvulsant medications
-
Stewart LS. Anticonvulsant medications. Emerg Med Serv. 2001;30:56-66.
-
(2001)
Emerg Med Serv.
, vol.30
, pp. 56-66
-
-
Stewart, L.S.1
-
142
-
-
0030875849
-
Bromism: intoxication from a rare anticonvulsant therapy
-
James LP, Farrar HC, Griebel ML, et al. Bromism: intoxication from a rare anticonvulsant therapy. Pediatr Emerg Care. 1997;13:268-270.
-
(1997)
Pediatr Emerg Care.
, vol.13
, pp. 268-270
-
-
James, L.P.1
Farrar, H.C.2
Griebel, M.L.3
|